当前位置: 首页 JCRQ2 期刊介绍(非官网)
Psoriasis-targets And Therapy

Psoriasis-targets And Therapy

SCIE

国际简称:PSORIASIS-TARGETS TH  参考译名:牛皮癣的目标和治疗

  • 中科院分区

    2区

  • JCR分区

    Q2

基本信息:
ISSN:2230-326X
是否OA:未开放
是否预警:否
TOP期刊:是
出版信息:
出版地区:United Kingdom
出版商:Dove Medical Press
出版语言:English
出版周期:1 issue/year
研究方向:DERMATOLOGY
评价信息:
影响因子:3.4
发文数据:
Gold OA文章占比:100.00%
研究类文章占比:85.42%
年发文量:48
自引率:0.0689...
开源占比:1
出版撤稿占比:
出版国人文章占比:0
OA被引用占比:1
英文简介 期刊介绍 中科院SCI分区 JCR分区 发文数据 常见问题

英文简介Psoriasis-targets And Therapy期刊介绍

Psoriasis Targeted Therapies is a professional journal dedicated to psoriasis and its treatment. This journal aims to publish the latest research findings on the pathogenesis, diagnosis, treatment, and management of psoriasis. As a peer-reviewed open access journal, it provides a platform for researchers, clinicians, and other healthcare professionals to share innovative research and clinical experiences.

Psoriasis is a chronic inflammatory skin disease characterized by the appearance of red patches on the skin covered with silver white scales. This disease not only affects the appearance of patients, but may also have significant impacts on their psychological and social life. Therefore, the publication of journals is of great significance in promoting the progress of psoriasis treatment. Journal content typically includes original research articles, reviews, clinical trial reports, case studies, and treatment guidelines. These contents help readers understand the complex biological and immunological background of psoriasis, as well as personalized treatment strategies for different subtypes and severity of the disease.

期刊简介Psoriasis-targets And Therapy期刊介绍

《Psoriasis-targets And Therapy》是一本医学优秀杂志。致力于发表原创科学研究结果,并为医学各个领域的原创研究提供一个展示平台,以促进医学领域的的进步。该刊鼓励先进的、清晰的阐述,从广泛的视角提供当前感兴趣的研究主题的新见解,或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道医学领域的最新进展和新发现新突破等。该刊近一年未被列入预警期刊名单,目前已被权威数据库SCIE收录,得到了广泛的认可。

该期刊投稿重要关注点:

中科院SCI分区Psoriasis-targets And Therapy 中科院分区

《新锐期刊分区表》(2026年3月发布) 综述期刊:否 Top期刊:否
大类学科 分区 小类学科 分区
医学 2区 DERMATOLOGY 皮肤病学 2区
期刊分区表(2025年3月升级版) 综述期刊:否 Top期刊:否
大类学科 分区 小类学科 分区
医学 3区 DERMATOLOGY 皮肤病学 2区

中科院分区表 是以客观数据为基础,运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据,得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次,类似于“优、良、及格”等。最开始,这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

JCR分区Psoriasis-targets And Therapy JCR分区

2025-2026年最新版
按JCI指标学科分区 收录子集 分区 排名 百分位
学科:DERMATOLOGY ESCI Q2 25 / 99

75.3

学科:DERMATOLOGY ESCI Q1 12 / 99

88.38

2023-2024年最新版
按JCI指标学科分区 收录子集 分区 排名 百分位
学科:DERMATOLOGY ESCI Q1 10 / 94

89.9

学科:DERMATOLOGY ESCI Q1 11 / 94

88.83

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异,此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此,JCR将期刊按照学科门类和影响因子分为不同的分区,这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

发文数据

国家/地区发文量统计
  • 国家/地区数量
  • USA10
  • Denmark3
  • Egypt3
  • Greece2
  • Indonesia2
  • Italy2
  • Netherlands2
  • Sweden2
  • Brazil1
  • Canada1

本刊中国学者近年发表论文

  • 1、Genetic Evidence Linking Immune Cell Subsets to Psoriatic Arthritis Susceptibility: A Mendelian Randomization Stud

    Author: Wang, Huiwei; Ma, Mingxuan; Wang, Chenfeng; Zhen, Yu; Li, Shanshan

    Journal: PSORIASIS-TARGETS AND THERAPY. 2026; Vol. 16, Issue , pp. -. DOI: 10.2147/PTT.S589733

  • 2、Persistence and Long-Term Disease Control of Interleukin-17 Inhibitors and Interleukin-23 Inhibitors in Patients with Psoriasis: A Nationwide Cohort Study in Japa

    Author: Xu, Youran; Li, Tong; Chang, Chia-Ling; Zhang, Yongjing; Masuda, Junya; Wu, Grace Hui-Min; Wahking, Bryan; Imafuku, Shinichi; Qiu, Hong

    Journal: PSORIASIS-TARGETS AND THERAPY. 2026; Vol. 16, Issue , pp. -. DOI: 10.2147/PTT.S565823

  • 3、The Psoriatic Disease Assessment Index (PSODAI) Score to Evaluate Systemic Involvement of Psoriasi

    Author: Liang, Yanhua; Deng, Baoqing; Ntawuyamara, Epipode; Bachelez, Herve; Wang, Fuxi; Zhang, Hao; Zhang, Zhenying; Li, Zhengfeng; Dang, Lin; Wang, Yajie; Zou, Xianbiao; Wang, Li; Duan, Dejian; Chen, Hongxiang; Zheng, Wenjun; Huang, Hui; Zhang, Min; Cai, Qingxian; Chen, Ye; Zhang, Yingli; Lu, Zeyuan; Ren, Yalin; Huang, Jinxian

    Journal: PSORIASIS-TARGETS AND THERAPY. 2026; Vol. 16, Issue , pp. -. DOI: 10.2147/PTT.S548700

  • 4、Successful Treatment of Two Rare Pediatric Keratinization Disorders with Secukinumab: Epidermolytic Ichthyosis and PRP-GPP Overla

    Author: Xu, Qianyue; Zhang, Jia

    Journal: PSORIASIS-TARGETS AND THERAPY. 2026; Vol. 16, Issue , pp. 1-6. DOI: 10.2147/PTT.S553794

  • 5、Bidirectional Associations Between Substance Abuse and Psoriasis: A Prospective Cohort Stud

    Author: Che, Xuanlin; Zhou, Jiatong; Wang, Anqi; Guo, Jia; Zhang, Chengcheng; Xiao, Yi

    Journal: PSORIASIS-TARGETS AND THERAPY. 2026; Vol. 16, Issue , pp. -. DOI: 10.2147/PTT.S557781

  • 6、Acupoint Injection Combined with BCG-PSN and Thymosin Enteric-Coated Tablets Improve China Han Psoriasis Vulgaris by Regulating T Cell Subset

    Author: Li, Junqin; Zhao, Xincheng; Pan, Hong; Duan, Yanping; Li, Wen; Zhao, Yanhong; Yao, Lifeng; Zhang, Kaiming

    Journal: PSORIASIS-TARGETS AND THERAPY. 2025; Vol. 15, Issue , pp. 209-220. DOI: 10.2147/PTT.S515285

  • 7、Dual Biologic Therapy for Psoriasis in a Patient with Atopic Dermatiti

    Author: Ma, Ling; Chen, Xiaoli; Aziz, Mohammed Ali Ali; Chen, Aijun; Cai, Tao; Chen, Shuang

    Journal: PSORIASIS-TARGETS AND THERAPY. 2025; Vol. 15, Issue , pp. 159-161. DOI: 10.2147/PTT.S516268

  • 8、Pediatric Pustular Psoriasis in Southern China: A 12-Year Retrospective Analysis of 41 Cases Focusing on Clinical Characteristics and Treatment Outcome

    Author: Tang, Jinling; Hou, Zhaojuan; Liao, Wei; Wang, Yuwei; Zhang, Ge; Luo, Yangyang; Gao, Xiaofei; Wei, Zhu

    Journal: PSORIASIS-TARGETS AND THERAPY. 2025; Vol. 15, Issue , pp. 185-195. DOI: 10.2147/PTT.S519385

投稿常见问题